False
October 3, 2025
The FDA has unveiled its top science and research priorities for FY 2026 under the GDUFA program, including nitrosamine risk, complex drug development, bioequivalence innovations, and the use of AI and modeling to modernize generics regulation.
2 min read
October 3, 2025
TransCelerate and ACRO have developed a free toolkit to help with the implementation of new guidance for Good Clinical Practice. We find out more.
7 min read
October 2, 2025
We speak with an expert from Sandoz about the need to boost biosimilar manufacturing capacity in Europe.
3 min read
October 2, 2025
UPenn researchers use AI to discover thousands of potential new antibiotics from ancient microbes.
2 min read
October 1, 2025
When Europe considered banning titanium dioxide in medicines, the pharma world braced for upheaval. With its short-term future in medicines secured, what’s next?
4 min read
False